KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Non Operating Income (2016 - 2017)

Jazz Pharmaceuticals has reported Non Operating Income over the past 3 years, most recently at -$1.5 million for Q1 2017.

  • Quarterly results put Non Operating Income at -$1.5 million for Q1 2017, down 78.75% from a year ago — trailing twelve months through Mar 2017 was -$3.0 million (down 87.28% YoY), and the annual figure for FY2015 was $1.4 million, down 83.36%.
  • Non Operating Income for Q1 2017 was -$1.5 million at Jazz Pharmaceuticals, down from -$749000.0 in the prior quarter.
  • Over the last five years, Non Operating Income for JAZZ hit a ceiling of $2.2 million in Q1 2015 and a floor of -$1.9 million in Q2 2015.
  • Median Non Operating Income over the past 3 years was -$819000.0 (2016), compared with a mean of -$226714.3.
  • Peak annual rise in Non Operating Income hit 23.34% in 2016, while the deepest fall reached 136.48% in 2016.
  • Jazz Pharmaceuticals' Non Operating Income stood at $2.1 million in 2015, then crashed by 135.82% to -$749000.0 in 2016, then tumbled by 95.46% to -$1.5 million in 2017.
  • The last three reported values for Non Operating Income were -$1.5 million (Q1 2017), -$749000.0 (Q3 2016), and -$819000.0 (Q1 2016) per Business Quant data.